Fine particulate matter - A health hazard for lungs and other organs? How do the particles get into the blood, and how do they exert their detrimental effects?;Feinstaub: Gefahr für lunge und kreislauf? "Was gelangt in den kreislauf und was macht es dort?"

Pneumologie

Volumn 60, Issue 10, 2006, Pages 611-615

  Schulz, Holger ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METAL; SODIUM CHLORIDE;

ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; ENDOCYTOSIS; ENDOTHELIAL DYSFUNCTION; HEALTH HAZARD; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HOMEOSTASIS; HUMAN; INFLAMMATION; LUNG; LUNG CAPILLARY; PARTICULATE MATTER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STRESS; SYSTEMIC CIRCULATION; TRANSCYTOSIS;

ARRHYTHMIA; HAZARDOUS SUBSTANCES; HUMANS; LUNG; LUNG DISEASES; PARTICULATE MATTER;

EID: 33750907501     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-954969     Document Type: Review

References (38)

1. United States Environmental Protection Agency. Air quality criteria for particulate matter, Volume I and II. 2004http://cfpub.epa.gov/ncea/cfm/partmatt. cfm
2. World Health Organization. Meta-analysis of time-series studies and panel studies of particulate matter (PM) and ozone (O3). Copenhagen: WHO Regional Office for Europe, 2004 (document EUR/04/5042688)http://www.euro.who.int/ document/E82792.pdf
3. Campen MJ, Nolan JP, Schladweiler MC et al. Cardiac and thermoregulatory effects of instilled particulate matter-associated transition metals in healthy and cardiopulmonary-compromised rats. J Toxicol Environ Health 2002; 65: 1615-1631
4. Gilmour PS, Nyska A, Schladweiler MC et al. Cardiovascular and blood coagulative effects of pulmonary zinc exposure. Toxicol Appl Pharmacol 2006; 211: 41-52
5. Kodavanti UP, Schladweiler MC, Ledbetter AD et al. Pulmonary and systemic effects of zinc-containing emission particles in three rat strains: multiple exposure scenarios. Toxicol Sci 2002; 70: 73-85
6. Chen J, Tan M, Nemmar A et al. Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. Toxicology 2006; 222: 195-201
7. Elder A, Gelein R, Finkelstein JN et al. Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. Toxicol Sci 2005; 88: 614-629
8. Kreyling WC, Semmler M, Erbe F et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health 2002; 65: 1513-1530
9. Kreyling WG, Semmler M, Moller W. Dosimetry and toxicology of ultrafine particles. J Aerosol Med 2004; 17: 140-152
10. Oberdorster G, Sharp Z, Atudorei V et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health 2002; 65: 1531-1543
11. Oberdorster G, Sharp Z, Atudorei V et al. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004; 16: 437-445
12. Semmler M, Seitz J, Erbe F et al. Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 2004; 16: 453-459
13. Takenaka S, Karg E, Roth C et al. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 2001; 109: 547-551
14. Takenaka S, Karg E, Kreyling WG et at. Fate and toxic effects of inhaled ultrafine cadmium oxide particles in the rat lung. Inhal Toxicol 2004; 16: 83-92
15. Wiebert P, Sanchez-Crespo A, Folk R et al. No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol 2006; 18: 741-747
16. Takenaka S, Karg E, Kreyling WC et al. Distribution pattern of inhaled ultrafine gold particles in the rat lung. Inhal Toxicol 2006; 18: 733-740
17. Geiser M, Rothen-Rutishauser B, Kapp N et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005; 113: 1555-1560
18. Kunzli N, Tager IB. Air pollution: from lung to heart. Swiss Med Wkly 2005; 135: 697-702
19. Peters A. Particulate matter and heart disease: Evidence from epidemiological studies. Toxicol Appl Pharmacol 2005; 207: 477-482
20. Schulz H, Harder V, Ibald-Mulli A et al. Cardiovascular effects of fine and ultrafine particles. J Aerosol Med 2005; 18: 1-22
21. Schwartz J, Park SK, O'Neill MS et al. Glutathione-S-transferase MI, obesity, statins, and autonomic effects of particles: gene-by-drug-by- environment interaction. Am J Respir Crit Care Med 2005; 172: 1529-1533
22. Harder V, Gilmour P, Lentner B et al. Cardiovascular responses in unrestrained WKY rats to inhaled ultrafine carbon particles. Inhal Toxicol 2005; 17: 29-42
23. Harder V, Schladweiler MC, Semmler M et al. Ultrafine carbon particle (UfCP) inhalation affects cardiovascular performance in hypertensive rats (SHR). Eur Respir J 2005; 49: 474S
24. Sun Q, Wang A, Jin X et al. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. JAMA 2005; 294: 303-310
25. Henneberger A, Zareba W, Ibald-Mulli A et al. Repolarization changes induced by air pollution in ischemic heart disease patients. Environ Health Persect 2005; 113: 440-446
26. Nadziejko C, Fang K, Narciso S et al. Effect of particulate and gaseous pollutants on spontaneous arrhythmias in aged rats. Inhal Toxicol 2004; 16: 373-80
27. Graff DW, Cascio WE, Brackhan JA et al. Metal particulate matter components affect gene expression and beat frequency of neonatal rat ventricular myocytes. Environ Health Perspect 2004; 112: 792-798
28. Nemmar A, Hoylaerts MT, Hoet PH et al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med 2002; 166: 998-1004
29. Nemmar A, Hoylaerts MF, Hoet PH et al. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol 2003; 186: 38-45
30. Nemmar A, Hoet PH, Dinsdale D et al. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation 2003; 107: 1202-1208
31. Nemmar A, Nemery B, Hoet PH et al. Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: role of histamine. Am J Respir Crit Care Med 2003; 168: 1366-1372
32. Nemmar A, Hoylaerts MF, Hoet PH et al. Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett 2004; 149: 243-253
33. Silva VM, Corson N, Elder A et al. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci 2005; 85: 983-989
34. Khandoga A, Stampft A, Takenaka S et al. Ultrafine particles exert prothrombotic but not inflammatory effects on the hepatic microcirculation in healthy mice in vivo. Circulation 2004; 109: 1320-1325
35. Kunzli N, Jerrett M, Mack WJ et al. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect 2005; 113: 201-206
36. Calderon-Garciduenas L, Maronpot RR, Torres-Jardon R et al. DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol Pathol 2003; 31: 524-538
37. Calderon-Garciduenas L, Reed W, Maronpot RR et al. Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicol Pathol 2004; 32: 650-658
38. Veronesi B, Makwana O, Pooler M et al. Effects of subchronic exposures to concentrated ambient particles. VII. Degeneration of dopaminergic neurons in Apo E-/- mice. Inhal Toxicol 2005; 17: 235-241